drugset / Trial / NCT00542464
Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection
RandomizedParallel-groupTriple-blind
Summary
The study is a Phase Ib, randomized, double-blind, placebo-controlled, multiple-dose (7 day), dose-escalation study assessing the safety, pharmacodynamics, and pharmacokinetics of intravenous Imprime PGG™ Injection in healthy adult subjects.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imprime PGG | Other / unclassified | 1 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 4 mg/kg | Intravenous |
Indications
No indication recorded.